Introduction: We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the Free and Cued Selective Reminding Test (FCSRT). Methods: The FCSRT was administered in 417 presymptomatic and symptomatic mutation carriers (181 chromosome 9 open reading frame 72 [C9orf72], 163 progran-ulin [GRN], and 73 microtubule-associated protein tau [MAPT]) and 290 controls. Group differences and correlations with other neuropsychological tests were examined. We performed voxel-based morphometry to investigate the underlying neural substrates of the FCSRT. Results: All symptomatic mutation carrier groups and presymptomatic MAPT mutation carriers performed significantly worse on all FCSRT scores compared to controls. In the presymptomati...
Although executive dysfunction is the characteristic cognitive marker of behavioral variant frontote...
textabstractBackground: Frontotemporal dementia is a highly heritable neurodegenerative disorder. In...
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (...
Introduction: We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the F...
Abstract: Introduction: We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) ...
IntroductionWe aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the Fre...
Introduction:We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the F...
Introduction: We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the F...
Introduction: We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the F...
The recently discovered hexanucleotide repeat expansion, C9ORF72, has been shown to be among the mos...
Background: Frontotemporal dementia is a highly heritable neurodegenerative disorder. In about a thi...
SummaryBackgroundFrontotemporal dementia is a highly heritable neurodegenerative disorder. In about ...
Although executive dysfunction is the characteristic cognitive marker of behavioral variant frontote...
AbstractThe recently discovered hexanucleotide repeat expansion, C9ORF72, has been shown to be among...
Although executive dysfunction is the characteristic cognitive marker of behavioral variant frontote...
Although executive dysfunction is the characteristic cognitive marker of behavioral variant frontote...
textabstractBackground: Frontotemporal dementia is a highly heritable neurodegenerative disorder. In...
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (...
Introduction: We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the F...
Abstract: Introduction: We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) ...
IntroductionWe aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the Fre...
Introduction:We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the F...
Introduction: We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the F...
Introduction: We aimed to assess episodic memory in genetic frontotemporal dementia (FTD) with the F...
The recently discovered hexanucleotide repeat expansion, C9ORF72, has been shown to be among the mos...
Background: Frontotemporal dementia is a highly heritable neurodegenerative disorder. In about a thi...
SummaryBackgroundFrontotemporal dementia is a highly heritable neurodegenerative disorder. In about ...
Although executive dysfunction is the characteristic cognitive marker of behavioral variant frontote...
AbstractThe recently discovered hexanucleotide repeat expansion, C9ORF72, has been shown to be among...
Although executive dysfunction is the characteristic cognitive marker of behavioral variant frontote...
Although executive dysfunction is the characteristic cognitive marker of behavioral variant frontote...
textabstractBackground: Frontotemporal dementia is a highly heritable neurodegenerative disorder. In...
Background and Objectives Disease-modifying therapeutic trials for genetic frontotemporal dementia (...